Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis - Wikidata - wikimedia - TriplyDB

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26861399

about

Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.Investigational drugs for treating agitation in persons with dementia.Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series.RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.Alzheimer Disease Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.Glutamatergic agents for OCD and related disorders Enhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.Medicare Part D payments for neurologist-prescribed drugs.The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.Effectiveness of a 16-Week Multimodal Exercise Program on Individuals With Dementia: Study Protocol for a Multicenter Randomized Controlled Trial.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.A Meta-Analysis of Memantine for Depression.Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.Post-acute delivery of memantine promotes post-ischemic neurological recovery, peri-infarct tissue remodeling, and contralesional brain plasticity.A Novel Small Molecule Modulator of Amyloid Pathology.Trends in Drug Prescription Rates for Dementia: An Observational Population-Based Study in France, 2006-2014.The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis.Physiological and pathophysiological control of synaptic GluN2B-NMDA receptors by the C-terminal domain of amyloid precursor protein.Neuroprotective effect of deferoxamine on N-methyl-d-aspartate-induced excitotoxicity in RGC-5 cells.Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.Kynurenine Pathway Metabolites in Alzheimer's Disease.Spatial recognition test: A novel cognition task for assessing topographical memory in mice.Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.

P2860

Q30234535-035CAC6B-8EDD-41C9-AB23-065D4FD4B894 Q30250076-121BC079-DC25-4597-A7D0-8CFAB0075F78 Q30400013-2227F0E2-EA9C-4309-8F10-1679948B66BB Q31134674-1092E72D-FAAD-489E-B223-051505F79815 Q33562441-E7248254-DCAA-4815-A50D-09B5B1880E0D Q35669030-E126C791-EE29-4BCA-B4C3-210A48DC8D48 Q35786464-97C8CD9D-2FB1-43ED-8D6C-82554BA4FC9C Q35967025-C7E9344D-D0B8-47CE-A485-7984143AB366 Q36729733-75DE0C15-5384-4DD8-892A-C9E07B7B538C Q36813242-92B0A93A-3A70-45A8-A492-E9B26D5C4BFA Q37388486-82DA8B73-9FD2-4D79-BC57-F23B0006BAE9 Q37710045-3D47FDE0-5E3D-4ADA-B55D-17A0299F469C Q38906350-F953269A-4E4D-4CE1-9BE8-C492C7C788EE Q39145461-08261B0C-3FA7-4678-9CE6-367D6490228A Q39244637-84AD9A47-ADEE-4286-ABF2-E7C1617F461D Q39244962-CBBA7A1E-C5C9-449F-B09F-FBC9E752232F Q39308929-BD65F117-8C41-4665-80EA-99F59393C693 Q39387480-056B23DE-F358-434E-8CEC-ECBEEC40902C Q39773096-E0E0C80B-677C-4D5C-8C6E-0F5E5785BFB4 Q39779155-4CAC4E68-5662-4519-9009-85053EDA6F16 Q40104512-340A90B7-F670-442C-85D6-51B7EDEEF019 Q41144379-C29C243C-9A08-4F36-855A-D5386E9198E1 Q41257684-9429233A-023C-493F-9F4F-C03D128686F3 Q47773091-14C650D8-38F6-45D2-B552-22928197FEC0 Q50023771-50A2DAD8-3995-4067-AE24-86FDE81CD402 Q50044080-3A918AB6-3B55-43BC-B599-4923CEC98CA0 Q50225528-F33F7C66-8F75-4B53-9BFA-96B0CF7CE23D Q50437756-83F6B3BE-724A-4A4F-853E-5AC68DA49B00 Q55039354-EDEB08BB-45C5-4D66-881B-7A806D440C31

P2860

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26861399

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@ast

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@en

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@nl

type

label

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@ast

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@en

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@nl

prefLabel

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@ast

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@en

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@nl

P1433

Q26861399-2B11D00D-96AD-487F-8499-D8AB06002162

P1476

Q26861399-0A6A560A-DDE4-4C04-9DC7-317007AC70A1

P2093

Q26861399-25A11E76-3C9F-4AD5-BD9B-D9CE6F649972

Q26861399-5CC2C158-8F4A-4BE8-AA85-5F47AC344795

P275

Q26861399-21AEC13B-3871-4F58-B8E8-20468C451A71

P2860

Q26861399-077277A5-FF76-4DEE-AD0F-C26F2C76097D

Q26861399-0D478211-2EFA-47DC-8DC2-EF098A14666C

Q26861399-1C1ECCDB-1A1D-4D01-82EF-DB7A795DC086

Q26861399-2396C19B-BD8A-4457-87FD-A5CEC7206377

Q26861399-28998A3E-A015-485B-9B41-7B8E942A5A9E

Q26861399-2B37AFD6-5A79-4945-A2D6-B3B97E0342DD

Q26861399-3827A7D8-9B4F-4D0A-A572-50EDA75EF2E9

Q26861399-390F2386-B623-4CAB-B7E9-9ABE586773C0

Q26861399-45A35240-1E8C-46F3-8296-E6B2543C57DA

Q26861399-4C557C16-E7DC-4D06-AFD5-007FD1EF7201

P304

Q26861399-58435064-8DC6-4E54-905D-15BB7B439AA3

P31

Q26861399-367F7F61-2348-4296-9C52-EF60A89ECA24

Q26861399-AC2FECF5-EEC3-43C1-AE81-E8888C802FEA

Q26861399-FA6002D6-B35A-4A2E-923F-53172552D8E5

P3181

Q26861399-19EB5B0C-A35B-4DB3-988A-8C4B76EB76F7

P356

Q26861399-637E29D9-FB4A-4E44-8903-F84F6E503DB9

P407

Q26861399-8C262EAE-740A-43D5-BB50-5CA77D2004A9

P433

Q26861399-88A669AB-583A-49BD-9220-FC02C39AA7F6

P478

Q26861399-9B4E515F-B9FE-4403-9C19-41A8FE33ED3B

P50

Q26861399-E610FAFF-5855-4D3E-A197-52F2BD9E8BA3

P5008

Q26861399-DEF0DF94-41B3-42DD-A380-A808F272604E

P577

Q26861399-91F4DF68-3A73-462E-8885-7829C5A583A2

P5875

Q26861399-36B93D7F-F623-429F-86DD-4AEF6ADA840A

P698

Q26861399-A10C0B49-2EA1-4EA7-A1A4-3E789D69F6A6

P921

Q26861399-4B34E5BB-262C-4388-8958-F049A8067DE2

Q26861399-4F94BE10-98A5-45DA-A78F-2D4FC7612EF7

Q26861399-4FFFA7C0-79B7-4D15-8490-356CDA036622

P932

Q26861399-5171FC44-4A7A-4D3E-A07D-04C762A7E26C

P3181

P356

JOURNAL.PONE.0123289

P1433

P1476

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

@en

P2093

Shinji Matsunaga

http://www.w3.org/2001/XMLSchema#string

Taro Kishi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Memantine for dementia

“Mini-mental state”

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan.

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease.

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.

P304

e0123289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

4772209

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0123289

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276108670

http://www.w3.org/2001/XMLSchema#string

P698

25860130

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4393306

http://www.w3.org/2001/XMLSchema#string